Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Filings indexed 3,405 across all filing types
Latest filing 2018-06-27 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
LYNPARZA: SIGNIFICANT PFS 1ST-LINE OVARIAN CANCER
Regulatory Filings
2018-06-27 English
Lynparza: significant PFS 1st-line ovarian cancer
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content describes positive Phase III trial results for a drug (Lynparza) and states that the companies 'plan to initiate discussions with health authorities regarding regulatory submissions.' This is a press release announcing significant clinical trial data, which is typically classified as an Earnings Release (ER) if it relates to periodic results, or a Regulatory Filing (RNS) if it's a general announcement of material information. Since this is a specific, material announcement of clinical trial success that will lead to regulatory action, and it is explicitly marked as an RNS release, the most appropriate general category for material, non-periodic corporate news disseminated via RNS is RNS, although ER might also be considered if it were tied to a quarterly report. Given the structure and the explicit RNS header, RNS is the best fit as a general regulatory disclosure. FY 2018
2018-06-27 English
BOARD COMMITTEE CHANGES
Regulatory Filings
2018-06-26 English
Board Committee Changes
Board/Management Information Classification · 98% confidence The document is identified by the 'RNS Number : 5247S' header and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange. The content details specific changes to the company's Board Committees (Science, Audit, Remuneration, Nomination and Governance), which constitutes an announcement regarding management and governance structure. This type of announcement, especially when disseminated via RNS, fits best under the 'Board/Management Information' category (MANG). While it is an RNS filing, MANG is more specific than the general RNS fallback.
2018-06-26 English
PUBLICATION OF A PROSPECTUS
Regulatory Filings
2018-06-22 English
Publication of a Prospectus
Regulatory Filings Classification · 98% confidence The document explicitly starts with an 'RNS Number' and the title 'Publication of Prospectus'. It announces that a Prospectus related to the Euro Medium Term Note (EMTN) programme has been approved and is available for viewing via a URL, and a copy has been submitted to the National Storage Mechanism (NSM). This structure—a brief announcement stating that a formal document (a Prospectus, which is a financing/capital document) has been published and providing links—fits the definition of a Report Publication Announcement (RPA). Although it relates to financing (CAP), the document itself is the announcement of the publication, not the detailed financing terms or the prospectus itself. Given the short length (2692 chars) and the focus on announcing availability, RPA is the most appropriate classification based on Rule 2.
2018-06-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.